Recovery Rank for 180 countries/regions
Recovery Rank for 184 countries/regions
Recovery Index 60.02 (Out of 100)
(100 = Best, 0 = Worst)
Recovery Index 55.09 (Out of 100)
Severity Index 19.84 (Out of 100)
(0 = Best, 100 = Worst)
Severity Index 38.13 (Out of 100)
N/A
(100 = Strictest Measures, 0 = No Measures)
(Medium Density)
15,890
1. Passengers must have a COVID-19 vaccination certificate showing that they were fully vaccinated at least 2 weeks before arrival. Vaccines accepted are: AstraZeneca (SKBioscience), AstraZeneca (Vaxzevria), Covaxin, Covishield, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac and Sputnik V. - This does not apply topassengers younger than 18 years. 2. Passengers entering or transiting through Antigua and Barbuda must have a negative COVID-19 antigen or RT-PCR test taken at most 4 days before departure from the firstembarkation point. The test must be based on nasopharyngeal or oropharyngeal swab. The list of approved antigen tests can be found at https://tinyurl.com/2p988z5a - This does notapply to passengers younger than 5 years. 3. Passengers are subject to medical screening upon arrival. 4. Passengers are subject to quarantine for up to 14 days at their own expense. - This does not apply to passengers with a COVID-19 vaccination certificate showing that they werefully vaccinated at least two weeks before arrival. Vaccines accepted are: AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covaxin, Covishield, Janssen, Moderna (Spikevax),Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac and Sputnik V. 5. Passengers could be subject to COVID-19 test upon arrival at their own expense. 6. Passengers and airline crew staying overnight in transit must stay at a hotel or at a designated facility until their next flight. 7. More COVID-19 related information can be found at https://visitantiguabarbuda.com/travel-advisory/
Travel Advisory information provided and published with permission by IATA. (Timatic COVID-19 Alerts Service has been discontinued on 1/1/2022, please refer this page for latest travel advisory)
The number of daily confirmed cases has been used as an estimation of how severe the COVID-19 situation is in a given country. However, we’ve found that focusing on the country’s cumulative number of active cases gives a clearer picture of whether the infection curve is flattening.
The GCI Recovery Forecasting methodology relies on a Monte Carlo simulation model as we recognise that the factors that contribute to an increase / decrease in confirmed COVID19 cases are highly variable and subject to various localised circumstances and interventions. The P10 / P50 / P90 are probabilities assigned to the forecasts, with P10 being highly optimistic, and P90 being very conservative on recovery and reduction in cases. The forecast model is updated daily based on the latest case data.
Reviewed and Endorsed by:
In Collaboration andPartnership with:
Recognition and Award:
Chairman's Award
Key Sponsor: